Jorge Castro Garza

Dr. Jorge Castro Garza

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2002 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
XXXX XX
XX XX
KHKakul Husain
Kakul Husain
MGM.T Gonzalez Garza
M.T Gonzalez Garza
DCDelia E Cruz-Vega
Delia E Cruz-Vega
JGJorge Castro Garza
Jorge Castro Garza
AAAmir Azam
Amir Azam

29 January 2002 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
NBNeelam Bharti
Neelam Bharti
SHShailendra
Shailendra
MGM.T. Gonzalez Garza
M.T. Gonzalez Garza
DCDelia E. Cruz-Vega
Delia E. Cruz-Vega
JGJorge Castro Garza
Jorge Castro Garza
AAAmir Azam
Amir Azam

13 March 2008 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
DCDelia Elva Cruz‐Vega
Delia Elva Cruz‐Vega
MSMaria Julia Star
Maria Julia Star
NSNoé Salinas‐González
Noé Salinas‐González
BRBibiana Rosales‐Hernández
Bibiana Rosales‐Hernández
IEIris Estrada‐García
Iris Estrada‐García
JGJorge Castro Garza
Jorge Castro Garza

1 January 2014 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
CMCarmen Molina-Torres
Carmen Molina-Torres
ABAlejandra Barba-Marines
Alejandra Barba-Marines
OVOrestes Valles-Guerra
Orestes Valles-Guerra
JOJorge Ocampo-Candiani
Jorge Ocampo-Candiani
NCNorma Cavazos-Rocha
Norma Cavazos-Rocha
LVLucio Vera-Cabrera
Lucio Vera-Cabrera
Due to the emergency of multidrug-resistant strains of Mycobacterium tuberculosis, is necessary the evaluation of new compounds.

1 March 1988 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
SSSalvador Said-Fernández
Salvador Said-Fernández
JVJavier Vargas-Villarreal
Javier Vargas-Villarreal
JGJorge Castro Garza
Jorge Castro Garza
BMBenito D. Mata-Cárdenas
Benito D. Mata-Cárdenas
LNLeticia Navarro-Marmolejo
Leticia Navarro-Marmolejo
HMHerminia Martínez-Rodríguez
Herminia Martínez-Rodríguez
Knowledge of Entamoeba histolytica biology in the last 17 years has been acquired largely as a consequence of this parasite's axenic cultivation in TPS-1 or TYI-S-33 media. Unfortunately, there are often low yields in these media, due to variability of their main components, Panmede and yeast extract. We describe a medium, PEHPS, of which the main components are extracts of ox liver, and ox and swine pancreas (EHP). 5 strains of E. histolytica and 2 of E. invadens were quickly and easily adapted to PEHPS and serially cultivated for 3 years. Yields progressively rose initially, and then became stable. Depending on the strain, average yields in the last 6 months of this study were 1.3 to 3.1 x 10(5) amoebae/ml for E. histolytica and 5.5 to 5.7 x 10(5) for E. invadens. All the 18 EHP batches tested supported vigorous amoebal growth. PEHPS had 2 additional advantages: (a) it was stable at 4 degrees C or 25 degrees C for 9 months, and at -10 degrees C for at least 2 years, and (b) it supported amoebal growth with inocula as low as one trophozoite/ml. PEHPS avoids the variability shown by TPS-1 and TYI-S-33, and could therefore be a good alternative for axenic amoebal cultivation.

16 August 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JGJorge Castro Garza
Jorge Castro Garza
PGPaola García-Jacobo
Paola García-Jacobo
LRLydia G. Rivera-Morales
Lydia G. Rivera-Morales
FQFrederick D. Quinn
Frederick D. Quinn
JBJames Barber
James Barber
CRCristina Rodríguez-Padilla
Cristina Rodríguez-Padilla
Mycobacterium tuberculosis is a pathogen causing tuberculosis (TB) a spectrum of disease including acute and asymptomatic latent stages. Identifying and treating latently-infected patients constitutes one of the most important impediments to TB control efforts. Those individuals can remain undiagnosed for decades serving as potential reservoirs for disease reactivation. Tests for the accurate diagnosis of latent infection currently are unavailable. HspX protein (α-crystallin), encoded by Rv2031c gene, is produced in vitro by M. tuberculosis during stationary growth phase and hypoxic or acidic culture conditions. In this study, using standard, and Luminex xMAP® bead capture ELISA, respectively, we report on detection of anti-HspX IgG and IgM antibodies and HspX protein in sera from acute and latent TB patients. For the antibody screen, levels of IgG and IgM antibodies were similar between non-infected and active TB patients; however, individuals classified into the group with latent TB showed higher values of anti-HspX IgM (p = 0.003) compared to active TB patients. Using the bead capture antigen detection assay, HspX protein was detected in sera from 56.5% of putative latent cases (p< 0.050) compared to the background median with an average of 9,900 pg/ml and a range of 1,000 to 36,000 pg/ml. Thus, presence of anti-HspX IgM antibodies and HspX protein in sera may be markers of latent TB.